331 related articles for article (PubMed ID: 26654631)
1. Evaluating the effects of Danhong injection in treatment of acute ischemic stroke: study protocol for a multicenter randomized controlled trial.
Li B; Wang Y; Lu J; Liu J; Yuan Y; Yu Y; Wang P; Zhao X; Wang Z
Trials; 2015 Dec; 16():561. PubMed ID: 26654631
[TBL] [Abstract][Full Text] [Related]
2. Danhong injection in the treatment of chronic stable angina: study protocol for a randomized controlled trial.
Wang PQ; Li DD; Dong W; Liu J; Yu YN; Shen CT; Chen QG; Chen BW; Chen YD; Wang Z
Trials; 2015 Oct; 16():474. PubMed ID: 26489511
[TBL] [Abstract][Full Text] [Related]
3. Xingnaojing for Moderate-to-severe Acute ischemic Stroke (XMAS): study protocol for a randomized controlled trial.
Lai X; Cao K; Kong L; Liu Q; Gao Y;
Trials; 2017 Oct; 18(1):479. PubMed ID: 29037226
[TBL] [Abstract][Full Text] [Related]
4. The effect of Danshen extract on lipoprotein-associated phospholipase A
Chen AD; Wang CL; Qin Y; Tian L; Chen LB; Yuan XM; Ma LX; Wang YF; Sun JR; Wang HS; Dai N;
Trials; 2017 Dec; 18(1):606. PubMed ID: 29262859
[TBL] [Abstract][Full Text] [Related]
5. Clinical assessment of Shenfu injection loading in the treatment of patients with exacerbation of chronic heart failure due to coronary heart disease: study protocol for a randomized controlled trial.
Liu C; Hou Y; Wang X; Zhao Z; Liu Z; Zhai J; Mao J; Shang H
Trials; 2015 May; 16():222. PubMed ID: 25994188
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of add-on Danhong injection in patients with unstable angina pectoris: A double-blind, randomized, placebo-controlled, multicenter clinical trial.
Chen L; Fu G; Hua Q; Zhu HY; Deng Y; Wu W; Zhao YJ; Yang XY; Yang BS; Zhou YB; Liu J; Yu YN; Chen BW; Wang X; Wang Z
J Ethnopharmacol; 2022 Feb; 284():114794. PubMed ID: 34732357
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of the effects of Danhong injection with different doses on ischemic stroke: A substudy of hospital-based Danhong injection registry.
Du Y; Zhong L; Wu S; Wang X
J Tradit Chin Med; 2018 Dec; 38(6):917-925. PubMed ID: 32186140
[TBL] [Abstract][Full Text] [Related]
8. Re-evaluate the Efficacy and Safety of Human Urinary Kallidinogenase (RESK): Protocol for an Open-Label, Single-Arm, Multicenter Phase IV Trial for the Treatment of Acute Ischemic Stroke in Chinese Patients.
Ni J; Qu J; Yao M; Zhang Z; Zhong X; Cui L;
Transl Stroke Res; 2017 Aug; 8(4):341-346. PubMed ID: 28265861
[TBL] [Abstract][Full Text] [Related]
9. Effect and Safety of Hydroxysafflor Yellow A for Injection in Patients with Acute Ischemic Stroke of Blood Stasis Syndrome: A Phase II, Multicenter, Randomized, Double-Blind, Multiple-Dose, Active-Controlled Clinical Trial.
Hu MZ; Zhou ZY; Zhou ZY; Lu H; Gao M; Liu LM; Song HQ; Lin AJ; Wu QM; Zhou HF; Li L; Wang X; Cai YF
Chin J Integr Med; 2020 Jun; 26(6):420-427. PubMed ID: 32361934
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Complementary Treatment with Yiqi Fumai Lyophilized Injection on Acute Decompensated Ischemic Heart Failure (ACT-ADIHF): Rationale and Design of a Multicenter, Randomized, Controlled Trial.
Wang X; Zhao Z; Hou Y; Tang E; Zhao G; Wang S; Bi Y; Zhong C; Ren M; Zhang J; Mao J; Zhang B
Cardiovasc Drugs Ther; 2018 Jun; 32(3):295-300. PubMed ID: 29713851
[TBL] [Abstract][Full Text] [Related]
11. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.
Oskouei DS; Rikhtegar R; Hashemilar M; Sadeghi-Bazargani H; Sharifi-Bonab M; Sadeghi-Hokmabadi E; Zarrintan S; Sharifipour E
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e557-63. PubMed ID: 23871729
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of Lian-Ju-Gan-Mao capsules for treating the common cold with wind-heat syndrome: study protocol for a randomized controlled trial.
Wang S; Jiang H; Yu Q; She B; Mao B
Trials; 2017 Jan; 18(1):2. PubMed ID: 28057058
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of Y-2 sublingual tablet for patients with acute ischaemic stroke: protocol of a phase III randomised double-blind placebo-controlled multicentre trial.
Fu Y; Tang R; Chen R; Wang A; Ren J; Zhu S; Feng X; Fan D
Stroke Vasc Neurol; 2024 Feb; 9(1):90-95. PubMed ID: 37308251
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke.
Gulati A; Agrawal N; Vibha D; Misra UK; Paul B; Jain D; Pandian J; Borgohain R
CNS Drugs; 2021 Jan; 35(1):85-104. PubMed ID: 33428177
[TBL] [Abstract][Full Text] [Related]
15. Chinese medicine neuroaid efficacy on stroke recovery: a double-blind, placebo-controlled, randomized study.
Chen CL; Young SH; Gan HH; Singh R; Lao AY; Baroque AC; Chang HM; Hiyadan JH; Chua CL; Advincula JM; Muengtaweepongsa S; Chan BP; de Silva HA; Towanabut S; Suwanwela NC; Poungvarin N; Chankrachang S; Wong KS; Eow GB; Navarro JC; Venketasubramanian N; Lee CF; Bousser MG;
Stroke; 2013 Aug; 44(8):2093-100. PubMed ID: 23780952
[TBL] [Abstract][Full Text] [Related]
16. Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial.
Hong JM; Choi MH; Sohn SI; Hwang YH; Ahn SH; Lee YB; Shin DI; Chamorro Á; Choi DW;
Trials; 2018 Jul; 19(1):375. PubMed ID: 30005644
[TBL] [Abstract][Full Text] [Related]
17. Chinese herbal medicine bi min fang for allergic rhinitis: protocol for a double-blind, double-dummy, randomized controlled trial.
Luo Q; Zhou S; Li X; Chen Q; Lin W; Lu L; Li H; Chen C; Chen W; Li Y
Trials; 2019 Jan; 20(1):66. PubMed ID: 30658660
[TBL] [Abstract][Full Text] [Related]
18. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design to assess the efficacy and safety of HT047 in patients with acute ischemic stroke: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase II trial.
Heo SH; Song J; Kim BJ; Kim H; Chang DI;
Medicine (Baltimore); 2019 Oct; 98(43):e17655. PubMed ID: 31651889
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of Qishen granules in patients with chronic heart failure: study protocol for a randomized controlled trial.
Wang J; Shi J; Wei J; Wang J; Gao K; Li X; Chen J; Li S; Zhao H; Wang W
Trials; 2017 Oct; 18(1):468. PubMed ID: 29017565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
